Bisphosphonates and osteonecrosis of the Jaws: A primer for physicians for management and risk identification

Irish Medical Journal

Volumn 101, Issue 3, 2008, Pages

  O'Neill, P Rory ^a   Hopeck, J ^a  

^a TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CARBOXY TERMINAL TELOPEPTIDE; CHLORHEXIDINE; CLOTRIMAZOLE; NYSTATIN; BONE DENSITY CONSERVATION AGENT;

ALCOHOL CONSUMPTION; ANAMNESIS; ANTIANGIOGENIC ACTIVITY; BONE METASTASIS; BONE NECROSIS; DEBRIDEMENT; DENTAL SURGERY; DIFFERENTIAL DIAGNOSIS; DRUG HALF LIFE; EDITORIAL; HEALTH PRACTITIONER; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTERNALIZATION; JAW DISEASE; MOUTH HYGIENE; OSTEOCLAST; OSTEOPOROSIS; PERIODONTAL DISEASE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTOR; SMOKING; TOOTH RADIOGRAPHY; TREATMENT DURATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HEALTH; JAW;

BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; HUMANS; JAW; ORAL HEALTH; OSTEONECROSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 46349100902     PISSN: 03323102     EISSN: 03323102     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)

1. Clarke BM, Boyette J, Vural E, Suen JY, Anaissie EJ, Stack BC Jr. Bisphosphonates and jaw osteonecrosis: the UAMS experience. Otolaryngol Head Neck Surg. 2007 Mar; 136(3):396-400.
2. Barker, Kate and Simon Rogers. Bisphosphonate-associated Osteonecrosis of the jaws: a guide for the general dental practitioner. Dent Update. 2006 Jun; 33(5):270-2, 275.
3. Ruggiero, SL, et al. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging, and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Oct; 102(4):433-41. Epub 2006 Jul 31.
4. Woo S-B, Hellstein JW, Kalmar JR 2006 Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Int Med 144:753-761.
5. Lacy, MQ, et al. Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma. Mayo Clin Proc. 2006 Aug; 81(8):1047-53.
6. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonateinduced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk factors, Recognition, prevention, and Treatment. J Oral Maxillofac Surg 2005; 63(11):1567-75.
7. American Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: Expert panel recommendations. J Am Dent Assoc 2006 137: 1144-1150.
8. AAP Statement on Bisphosphonates, 2006. Available at www.perio.org.
9. Khamaisi, Mogher, et al. Possible Association Between Diabetes and Bisphosphonate-Related Jaw Osteonecrosis. J Clin Endocrinol Metab. 2006 Dec 19.
10. Migliorati, CA, et al. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc. 2005 Dec; 136 (12):1658-68. Review. Erratum in: J Am Dent Assoc. 2006 Jan; 137(1):26.
11. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonaterelated osteonecrosis of the jaws. J Oral Maxillofac Surg. 2007 Mar; 65(3):369-76.